Form 4: BioAtla CEO's Routine Tax Withholding of Shares

BioAtla's CEO, Jay M. Short, reported a routine withholding of 6,347 common shares by the issuer to cover tax obligations related to restricted stock unit vesting.

Summary

• Jay M. Short, PhD, Chief Executive Officer, Director, and 10% Owner of BioAtla, Inc. (BCAB), reported a transaction on November 30, 2025.
• The transaction involved the disposition of 6,347 shares of common stock at a price of $0.904 per share.
• This disposition was not a sale by Mr. Short but rather shares withheld by BioAtla to satisfy income tax and withholding obligations associated with the vesting and net settlement of previously reported restricted stock units.
• Following this transaction, Mr. Short directly beneficially owns 2,237,331 shares and indirectly owns 1,613,375 shares through various entities and his spouse.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation and tax obligations. It has a neutral impact on the company's operational or financial outlook.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not reflect specific industry trends or competitive positioning.

Related Party Transactions

• The transaction involves the issuer withholding shares from its CEO to cover tax obligations related to his compensation, which is a standard related-party transaction in the context of executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary tax-related transaction and not a sale by the insider.
• Employees: No direct impact on general employees.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

The Form 4 filing details a routine tax withholding of shares from the CEO's restricted stock units. This is a non-discretionary event and does not reflect a change in the CEO's investment conviction or the company's operational performance or future prospects. Therefore, it provides no new information to warrant a change in investment recommendation.

Keywords

BioAtla, BCAB, Jay M. Short, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, CEO, Director, 10% Owner